Trastuzumab pamirtecan, an investigational HER2-targeted antibody-drug conjugate, met the primary efficacy endpoint in a Phase …
Daily Archives
April 11, 2026
-
BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer
by Asia Insider -
DPC Dash – Domino’s Pizza China Delivers Strong Expansion in Q1 2026, Highlighting Scalable & Replicable Store Economics
by Asia InsiderHONG KONG, April 11, 2026 /PRNewswire/ — DPC Dash Ltd – Domino’s Pizza China ("DPC …